Fabio García-García

Prof. Dr. Fabio García-García

Instituto de Ciencias de la Salud, Universidad Veracruzana, Xalapa, Veracruz, Mexico
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Brain Research
Verified
Journal Article
Closed access
HYHitoshi Yoshida
Hitoshi Yoshida
ZPZoltan Peterfi
Zoltan Peterfi
Fabio García-GarcíaFabio García-García
Fabio García-García
RKRobert Kirkpatrick
Robert Kirkpatrick
TYTadanobu Yasuda
Tadanobu Yasuda
JKJames M Krueger
James M Krueger

1 September 2014 in Synapse
Verified
Journal Article
Closed access
PDF file
EAEva Acosta‐Peña
Eva Acosta‐Peña
ICIsrael Camacho‐Abrego
Israel Camacho‐Abrego
MMMontserrat Melgarejo‐Gutiérrez
Montserrat Melgarejo‐Gutiérrez
GFGonzalo Flores
Gonzalo Flores
RDRené Drucker‐Colín
René Drucker‐Colín
Fabio García-GarcíaFabio García-García
Fabio García-García

1 February 2005 in SLEEP
Verified
Journal Article
Open access
PDF file
TYTadanobu Yasuda
Tadanobu Yasuda
HYHitoshi Yoshida
Hitoshi Yoshida
Fabio García-GarcíaFabio García-García
Fabio García-García
DKDaniel Kay
Daniel Kay
JKJames M. Krueger
James M. Krueger
To investigate the hypothesis that interleukin (IL)-1β is involved in mediating localized electroencephalogram synchronization. We evaluated bilateral cortical electroencephalograms after unilateral local application of IL-1β onto the somatosensory cortex of rats. Furthermore, we investigated the effects of unilateral application of an IL-1β inhibitor, the IL-1 soluble receptor, on spontaneous sleep and sleep rebound after sleep deprivation. University research laboratory. N/A. Rats Neither dose of IL-1β or the IL-1 soluble receptor affected the duration of non-rapid eye movement sleep or rapid eye movement sleep. Unilateral application of IL-1β induced state- and frequency-dependent electroencephalogram asymmetries. During non-rapid eye movement sleep, but not during other states, electroencephalographic slowwave activity was greater on the side that received IL-1β (10- and 50-ng doses). Electroencephalographic power in the higher frequencies was not affected by IL-1β in any state. Unilateral application of the IL-1 soluble receptor (0.1, 1.0 and 5.0 μg) had no effect on the spontaneous sleep electroencephalogram. In contrast, unilateral application of the IL-1 soluble receptor (5.0 μg) attenuated sleep deprivation-enhanced electroencephalographic slow-wave power ipsilaterally during non-rapid eye movement sleep. Results suggest that IL-1β can induce state-dependent localized increases of electroencephalographic delta wave power, suggesting an enhancement of sleep intensity within the cortex.

1 February 2014 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
Fabio García-GarcíaFabio García-García
Fabio García-García
EAEnrique Juarez Aguilar
Enrique Juarez Aguilar
JSJuan Santiago-Garcia
Juan Santiago-Garcia
DCDaniel P. Cardinali
Daniel P. Cardinali

14 January 2014 in Sleep Disorders
Verified
Journal Article
Open access
PDF file
AHAlberto K. De la Herrán-Arita
Alberto K. De la Herrán-Arita
Fabio García-GarcíaFabio García-García
Fabio García-García
Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypnagonic hallucinations, sleep paralysis, and disturbed nocturnal sleep patterns. This disease is secondary to the specific loss of hypothalamic hypocretin (orexin)-producing neurons in the lateral hypothalamus. An autoimmune basis for the disease has long been suspected based on its strong association with the genetic marker DQB1*06:02, and current studies greatly support this hypothesis. Narcolepsy with hypocretin deficiency is associated with human leukocyte antigen (HLA) and T cell receptor (TCR) polymorphisms, suggesting that an autoimmune process targets a peptide unique to hypocretin-producing neurons via specific HLA-peptide-TCR interactions. This concept has gained a lot of notoriety after the increase of childhood narcolepsy in 2010 following the 2009 H1N1 pandemic (pH1N1) in China and vaccination with Pandemrix, an adjuvanted H1N1 vaccine that was used in Scandinavia. The surge of narcolepsy cases subsequent to influenza A H1N1 infection and H1N1 vaccination suggests that processes such as molecular mimicry or bystander activation might be crucial for disease development.

18 August 2022 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
LLLuis Angel López-Muciño
Luis Angel López-Muciño
Fabio García-GarcíaFabio García-García
Fabio García-García
Jonathan Cueto-EscobedoJonathan Cueto-Escobedo
Jonathan Cueto-Escobedo
MAMario Acosta-Hernández
Mario Acosta-Hernández
AVArturo Venebra-Muñoz
Arturo Venebra-Muñoz
JRJuan Carlos Rodríguez-Alba
Juan Carlos Rodríguez-Alba